Injectafer side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Injectafer. Common side effects include anhedonia among females and anhedonia among males.

The phase IV clinical study is created by eHealthMe based on 3,069 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 28, 2023

3,069 people who take Injectafer and have side effects are studied.

What is Injectafer?

Injectafer has active ingredients of ferric carboxymaltose. eHealthMe is studying from 3,072 Injectafer users for its effectiveness, alternative drugs and more.

Number of Injectafer reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Injectafer?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on ferric carboxymaltose (the active ingredients of Injectafer) and Injectafer (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Injectafer:

Injectafer (3,072 reports)

Common Injectafer side effects:

Pain: 338 reports
Breathing difficulty: 290 reports
Stress and anxiety: 257 reports
Chest pain: 256 reports
Headache (pain in head): 255 reports
Dizziness: 214 reports
Rashes (redness): 202 reports

All Injectafer side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Cefadroxil and Type 2 Diabetes - 2 seconds ago
Cefadroxil and Diabetes Mellitus Non-Insulin-Dependent - 2 seconds ago
Zymar and High Blood Cholesterol - 8 seconds ago
Norvasc and Folvite drug interaction - 38 seconds ago
Carboprost Tromethamine and Rales - 48 seconds ago
Nexium 24Hr and Myocardial Ischaemia - 52 seconds ago
Clozapine and Basaglar drug interaction - 55 seconds ago
Crestor and Cefazolin drug interaction - 57 seconds ago
Pain In Extremity and Pneumonia Haemophilus - 58 seconds ago
Losartan and Svc Obstruction - a minute ago